CRYSTAL AROZ: Open Payments
NPI 1962191700 · SAFFORD, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 19 payments from 10 companies in 2025. Trend: 2023 $84 · 2024 $351 · 2025 $322
Food & beverage: $302Education: $20
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Lilly USA, LLC | 3 | $48 |
| Exact Sciences Corporation | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Novo Nordisk Inc | 2 | $30 |
| Astellas Pharma US Inc | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: Kerendia, AIRSUPRA, KISUNLA, XIFAXAN, Veozah, VRAYLAR, GEMTESA, Cologuard Collection Kit.
Industry payments across AZ — which companies pay providers there.
